Evidence map›Paper›PMID 34490075›Full record

ArticleFrontiers in oncology2021

Effective Organs-at-Risk Dose Sparing in Volumetric Modulated Arc Therapy Using a Half-Beam Technique in Whole Pelvic Irradiation.

Hyunsoo Jang, Jiyeon Park, Mark Artz, Yawei Zhang, Jacob C Ricci, Soon Huh, Perry B Johnson, Mi-Hwa Kim, Mison Chun, Young-Taek Oh and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Dosimetric benefits of half-field arc in prostate cancer treatment.Physical and engineering sciences in medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Hyunsoo JangDepartment of Radiation Oncology, Dongguk University College of Medicine, Gyeongju, South Korea.
Jiyeon ParkDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, United States.
Mark ArtzDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, United States.
Yawei ZhangDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, United States.
Jacob C RicciDepartment of Radiation Oncology, Orlando Health Cancer Institute, Orlando, FL, United States.
Soon HuhDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, United States.
Perry B JohnsonDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, United States.
Mi-Hwa KimDepartment of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.
Mison ChunDepartment of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.
Young-Taek OhDepartment of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.
O Kyu NohDepartment of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.
Hae-Jin ParkDepartment of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.
Ajou University · KRFlorida College · USUniversity of Florida · USDongguk University · KROrlando Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough there are some controversies regarding whole pelvic radiation therapy (WPRT) due to its gastrointestinal and hematologic toxicities, it is considered for patients with gynecological, rectal, and prostate cancer. To effectively spare organs-at-risk (OAR) doses using multi-leaf collimator (MLC)'s optimal segments, potential dosimetric benefits in volumetric modulated arc therapy (VMAT) using a half-beam technique (HF) were investigated for WPRT.

methodsWhile the size of a fully opened field (FF) was decided to entirely include a planning target volume in all beam's eye view across arc angles, the HF was designed to use half the FF from the isocenter for dose optimization. The left or the right half of the FF was alternatively opened in VMAT-HF using a pair of arcs rotating clockwise and counterclockwise. Dosimetric benefits of VMAT-HF, presented with dose conformity, homogeneity, and dose-volume parameters in terms of modulation complex score, were compared to VMAT optimized using the FF (VMAT-FF). Consequent normal tissue complication probability (NTCP) by reducing the irradiated volumes was evaluated as well as dose-volume parameters with statistical analysis for OAR. Moreover, beam-on time and MLC position precision were analyzed with log files to assess plan deliverability and clinical applicability of VMAT-HF as compared to VMAT-FF.

resultsWhile VMAT-HF used 60%-70% less intensity modulation complexity than VMAT-FF, it showed superior dose conformity. The small intestine and colon in VMAT-HF showed a noticeable reduction in the irradiated volumes of up to 35% and 15%, respectively, at an intermediate dose of 20-45 Gy. The small intestine showed statistically significant dose sparing at the volumes that received a dose from 15 to 45 Gy. Such a dose reduction for the small intestine and colon in VMAT-HF presented a significant NTCP reduction from that in VMAT-FF. Without sacrificing the beam delivery efficiency, VMAT-HF achieved effective OAR dose reduction in dose-volume histograms.

conclusionsVMAT-HF led to deliver conformal doses with effective gastrointestinal-OAR dose sparing despite using less modulation complexity. The dose of VMAT-HF was delivered with the same beam-on time with VMAT-FF but precise MLC leaf motions. The VMAT-HF potentially can play a valuable role in reducing OAR toxicities associated with WPRT.

Indexed as

dose conformityhalf beamsmodulation complexity scorenormal tissue complication probability (NTCP)volumetric modulated arc therapywhole pelvic conformal radiotherapy

Identifiers

PMID34490075
PMCPMC8416480
OpenAlexW3195573091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.